HIGHFDA DRUG

Granules Pharmaceuticals Recall: 11,928 Bottles of Dextroamphetamine Mixed Salts Suspended for Impur

Granules Pharmaceuticals recalled 11,928 bottles of an extended-release amphetamine product. The recall date is 2025-08-28 for Dextroamphetamine saccharate and related salts. The FDA lists the reason as failed impurities and degradation specifications. The recall remains active as of 2025-10-01. Health care providers and patients should stop use and contact the manufacturer for guidance.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
August 28, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 28, 2025
Hazard Level
HIGH
Brand
Granules Pharmaceuticals
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PETS

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Granules Pharmaceuticals
Product type
Extended-Release Amphetamine Capsule
Model numbers
GPC250181A
UPC codes
70010-029, 70010-030, 70010-031, 70010-032, 70010-033, 70010-034, 70010-029-01, 70010-030-01 +4 more
Sizes
30 mg, 100 capsules per bottle
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 28, 2025

  2. Reported by FDA DRUG

    October 1, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Failed Impurities/Degradation Specifications:

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Granules Pharmaceuticals Inc. or your healthcare provider for guidance. Notification method: E-Mail

About This Product

This product is an extended-release amphetamine capsule formulated as a mixed salts product for ADHD. It is Rx-only and distributed nationwide in the USA.

Why This Is Dangerous

The failure to meet impurity and degradation specifications may affect safety and efficacy, potentially impacting patient treatment outcomes.

Industry Context

This recall is not shown as part of a broader industry pattern in the provided data.

Real-World Impact

Disruption to ADHD treatment; potential need for clinician adjustment and monitoring; immediate stop-use recommended.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 70010-034-01 on packaging
  2. Check for 30 mg strength and 100 capsules per bottle
  3. Confirm Granules Pharmaceuticals as the manufacturer

Where to find product info

FDA recall page and Granules Pharmaceuticals communications

What timeline to expect

Refund or replacement timelines not provided; consult FDA notice for updates

If the manufacturer is unresponsive

  • Document all contact attempts with the manufacturer
  • File a consumer complaint with the FDA if manufacturer is non-responsive
  • Seek guidance from your pharmacist or clinician

How to prevent similar issues

  • Verify manufacturers and NDC codes before dispensing/using medications
  • Watch for FDA recall updates and batch alerts
  • Consult prescribing clinician before stopping or changing medications

Documentation advice

Keep product packaging, recall notice, and all communications with the manufacturer; log lot numbers and dates of purchase

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, 30 mg, 100 capsules per bottle. Manufacturer: Granules Pharmaceuticals Inc., Chantilly, VA 20151. NDC: 70010-034-01. Classification: Class III. Distributed nationwide in the USA.

Reported Incidents

No specific injuries or incidents are reported in the recall notice. The FDA enforcement report lists the issue but does not detail injuries.

Key Facts

  • Class III recall
  • Nationwide distribution in the USA

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPETS
Injury Types
OTHER

Product Details

Model Numbers
GPC250181A
UPC Codes
70010-029
70010-030
70010-031
+9 more
Affected States
ALL
Report Date
October 1, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls